Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Clinical features of hyperandrogenism do not predict the success of conventional acne treatment in women.

Certain hormone treatments can improve acne and related conditions in women.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Androgens may influence bladder cancer progression by affecting cellular behavior.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Most antiandrogen treatments effectively reduce acne in hyperandrogenic women, but finasteride is the least effective.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.